PubMed HealthSearch

PubMed · 4004124

Multiple sclerosis--Indian experience.

Abstract

Multiple sclerosis (MS) does occur in India but it is rare. No epidemiological studies have been done. The calculations based on the hospital data suggest an approximate prevalence rate of 0.17 to 1.33 per 100,000 of population in different parts of India. One hundred and five patients with clinically definite MS (2 proven at autopsy) and 14 patients with neuromyelitis optica were seen in the Bombay region from 1957 to 1983. The mean age of onset for MS patients was 27.7 years. There were 60 female and 45 male patients. The clinical data in this larger series confirm the conclusions reached earlier, namely that the Indian MS patients are more akin to those reported from Japan and other Asian countries as compared to the West. The relative incidence of neuromyelitis optica was high (6%). The optico-spinal form of MS was the commonest (71.4%). In patients with clinically definite MS there was a high incidence of optic nerve involvement, both at the onset and during the course of the disease; sensory level occurred in a large number of patients and cerebellar involvement was less frequent. Multiple sclerosis in this series affected patients of all communities and different dietary habits. MS was more common in the higher socioeconomic group whereas neuromyelitis optica was mainly seen in patients in the low socioeconomic group.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B S Singhal. 1985. Multiple sclerosis--Indian experience.. https://pubmed.ncbi.nlm.nih.gov/4004124/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Human cerebrospinal fluid protein database: edition 1992.

Two-dimensional electrophoresis maps of human cerebrospinal fluid proteins are presented in the form of labeled images. 931 protein spots are identified in spinal fluid from a normal volunteer. Distinct spots that represent variants of the same protein, especially posttranslational modifications, are estimated to reduce the 931 different spots to < 200 different proteins. 248 spots of 29 protein groups have been identified and are indicated on enlargements of specific gel regions. The distribution of protein abundance, mass, charge and shape characteristics of these normal 931 spinal fluid spots are graphically profiled. Analysis of the shape parameter "vertical height: width ratio" reveals that a ratio > 3.5 correlates with glycoproteins, enabling their identification simply by image analysis. Proteins that are not present on the normal map, but appear in spinal fluid in patients with schizophrenia and Creutzfeldt-Jakob disease are illustrated on additional maps.

Cerebrospinal Fluid Proteins

Diffusion of contrast media in cerebrospinal fluid: comparison of iohexol, iopamidol and iotrolan in vitro.

Diffusion of iohexol (300 and 240 mgI/ml), iopamidol (300 and 200 mgI/ml), and iotrolan (300 and 240 mgI/ml) in the cerebrospinal fluid (CSF) of 16 patients was studied in vitro. Test tubes containing CSF were kept in a waterbath at 37 degrees C. Contrast medium was injected along the wall into the tubes, and diffusion of contrast media in the tubes was followed with repeated computed tomography for 5 h. The contents of the tubes were then mixed by shaking, and the tubes were scanned immediately and 8 h later. The contrast media first settled in the bottom of the tubes and then diffused upwards. Iotrolan diffused more slowly than the other media, but the difference was only significant at a concentration of 300 mgI/ml. The difference between iohexol and iopamidol was minimal. In general, diffusion was slower in CSF samples with an elevated protein content, but the difference in the diffusion of contrast medium in normal and pathological CSF was seldom statistically significant, perhaps owing to the small number of samples (5) with an elevated protein content. All contrast medium-CSF mixtures remained homogeneous after mixing. These experiments showed measurable differences in the diffusion of contrast media in CSF, but it does not seem very likely that these would be significant in clinical practice.

Cerebrospinal Fluid Proteins